Erste Asset Management Gmb H Incyte Corp Transaction History

Erste Asset Management Gmb H

$8.35 Trillion
Q3 2024

A detailed history of Erste Asset Management Gmb H transactions in Incyte Corp stock. As of the latest transaction made, Erste Asset Management Gmb H holds 51,200 shares of INCY stock, worth $3.71 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

51,200

Holding current value

$3.71 Million

% of portfolio

0.04%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$57.33 - $68.61 $2.94 Million - $3.51 Million	51,200 New	51,200 $3.37 Billion
Q3 2023 Nov 26, 2024	SELL	$57.77 - $65.93 $157,134 - $179,329	-2,720 Reduced 5.04%	51,200 $3 Billion
Q1 2023 Nov 26, 2024	SELL	$70.23 - $86.01 $191,025 - $233,947	-2,720 Reduced 5.04%	51,200 $3.64 Billion
Q3 2022 Nov 26, 2024	BUY	$66.18 - $82.86 $180,009 - $225,379	2,720 Added 5.31%	53,920 $3.59 Billion
Q2 2022 Nov 26, 2024	SELL	$66.18 - $83.18 $2.09 Million - $2.63 Million	-31,580 Reduced 36.94%	53,920 $4.09 Billion
Q1 2022 Nov 22, 2024	SELL	$66.02 - $79.71 $59,418 - $71,739	-900 Reduced 1.64%	54,000 $4.3 Billion
Q4 2021 Nov 22, 2024	BUY	$63.34 - $74.11 $234,358 - $274,207	3,700 Added 7.23%	54,900 $4.05 Billion
Q3 2021 Nov 22, 2024	SELL	$68.67 - $84.02 $192,276 - $235,256	-2,800 Reduced 4.85%	54,900 $3.77 Billion
Q2 2021 Nov 22, 2024	SELL	$79.87 - $87.53 $20,366 - $22,320	-255 Reduced 0.44%	57,700 $4.89 Billion
Q4 2020 Nov 22, 2024	SELL	$80.74 - $97.7 $833,236 - $1.01 Million	-10,320 Reduced 15.12%	57,955 $4.98 Billion
Q3 2020 Nov 22, 2024	BUY	$85.07 - $109.69 $1.45 Million - $1.87 Million	17,075 Added 33.35%	68,275 $5.97 Billion
Q2 2020 Nov 22, 2024	BUY	$74.18 - $108.93 $39,092 - $57,406	527 Added 0.71%	75,059 $7.7 Billion
Q1 2020 Nov 22, 2024	BUY	$63.18 - $85.97 $245,580 - $334,165	3,887 Added 5.5%	74,532 $5.38 Billion
Q4 2019 Nov 22, 2024	BUY	$73.04 - $95.72 $1.42 Million - $1.86 Million	19,445 Added 37.98%	70,645 $6.24 Billion
Q3 2019 Nov 22, 2024	BUY	$72.82 - $86.52 $11,432 - $13,583	157 Added 0.22%	72,295 $5.27 Billion
Q2 2019 Nov 22, 2024	SELL	$73.52 - $88.7 $982,374 - $1.19 Million	-13,362 Reduced 15.63%	72,138 $6.11 Billion
Q1 2019 Nov 22, 2024	BUY	$63.56 - $88.17 $2.18 Million - $3.02 Million	34,300 Added 66.99%	85,500 $7.33 Billion
Q4 2018 Nov 26, 2024	BUY	$58.5 - $69.94 $2.01 Million - $2.4 Million	34,300 Added 66.99%	85,500 $5.33 Billion

Others Institutions Holding INCY

# of Institutions

651

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.1B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Erste Asset Management Gmb H with notifications on news.

Account

Erste Asset Management Gmb H Incyte Corp Transaction History